$NASDAQ:ITCI

Potential Acquisition Targets: Alnylam and Intra-Cellular Therapies Lead the Way in Biotech Innovation

Trending News ☀️ INTRA-CELLULAR ($NASDAQ:ITCI): Potential biotech take-out targets, such as Alnylam and Intra-Cellular Therapies, are being closely watched. Intra-Cellular [...]

SG Americas Securities LLC Invests in Intra-Cellular Therapies, Reveals Made

Trending News ☀️ INTRA-CELLULAR ($NASDAQ:ITCI): SG Americas Securities LLC recently made a major announcement that they had obtained shares of [...]

Assenagon Asset Management Boosts Investment in Intra-Cellular Therapies,

Trending News ☀️ Intra-cellular Therapies Stock Fair Value – INTRA-CELLULAR ($NASDAQ:ITCI): Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company that [...]

By |January 13, 2023|Categories: Intrinsic Value|Tags: , , |0 Comments

Intra-Cellular Therapies Sees Significant Increase in Relative Strength Rating

Trending News ☀️ INTRA-CELLULAR ($NASDAQ:ITCI): Intra-Cellular Therapies is a biopharmaceutical company that focuses on the development of treatments for central [...]

Texas Teacher Retirement System Cuts Ties with Intra-Cellular Therapies,

Trending News 🌧️ Intra-cellular Therapies Intrinsic Value – INTRA-CELLULAR ($NASDAQ:ITCI): Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on the [...]

By |December 14, 2022|Categories: Intrinsic Value|Tags: , , |0 Comments
Go to Top